TWD 38.75
(-1.77%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.24 Billion TWD | -0.64% |
2022 | 1.25 Billion TWD | 5.93% |
2021 | 1.18 Billion TWD | 6.15% |
2020 | 1.11 Billion TWD | -14.46% |
2019 | 1.3 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.33 Billion TWD | 3.47% |
2024 Q3 | 1.25 Billion TWD | -6.55% |
2024 Q1 | 1.29 Billion TWD | 4.02% |
2023 Q4 | 1.24 Billion TWD | 1.64% |
2023 Q3 | 1.22 Billion TWD | -3.57% |
2023 Q2 | 1.26 Billion TWD | 2.54% |
2023 Q1 | 1.23 Billion TWD | -1.14% |
2022 FY | 1.25 Billion TWD | 5.93% |
2022 Q4 | 1.25 Billion TWD | 0.0% |
2021 FY | 1.18 Billion TWD | 6.15% |
2020 FY | 1.11 Billion TWD | -14.46% |
2019 FY | 1.3 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
BIONET Corp. | 2.34 Billion TWD | 47.045% |
Genetics Generation Advancement Corp. | 595.05 Million TWD | -109.012% |
Welgene Biotech Co.,Ltd. | 548.16 Million TWD | -126.891% |
Puriblood Medical Co., Ltd. | 265.51 Million TWD | -368.428% |
TFBS Bioscience Inc. | 1.44 Billion TWD | 14.109% |